Medifast Inc. (NYSE: MED) has reported earnings for its third fiscal quarter (ending September 30) of $0.10 versus $2.12 for the same period a year ago — a decline of -95%. For the latest four quarters through September 30, E.P.S. were $0.67 versus $11.01 for the same period a year ago — a decline of -94%.
Recent Price Action
Medifast Inc. (NYSE: MED) stock closed at $18.81 on 11/4/24 after an increase of 1.2%. Trading volume in this advance was normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 8.0% during the last week.
Current PriceTarget Research Rating
MED’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a Value Builder.
Medifast has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Medifast has a slightly negative Appreciation Score of 38 and a poor Power Rating of 21, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment